. 2018 May 28;19(3):393–405. doi: 10.4142/jvs.2018.19.3.393

Table 1. KNB-E2 pigs vaccinated with 75 µg, 50 µg, and 25 µg of E2 antigen developed high titers of anti-CSFV-neutralizing antibodies (ND₅₀) after CSFV challenge.

CSFV, classical swine fever virus; DPV, days post-vaccination; DPC, days post-challenge; (−/+), PBS-vaccinated, CSFV-challenged; (−/−), PBSvaccinated, non-challenged; PBS, phosphate-buffered saline. ^*Pig 166 euthanatized at 10 DPC; pig 167 euthanatized at 8 DPC; pig 169 euthanatized at 14 DPC.

Table 1. KNB-E2 pigs vaccinated with 75 µg, 50 µg, and 25 µg of E2 antigen developed high titers of anti-CSFV-neutralizing antibodies (ND50) after CSFV challenge.

Table 1. KNB-E2 pigs vaccinated with 75 µg, 50 µg, and 25 µg of E2 antigen developed high titers of anti-CSFV-neutralizing antibodies (ND₅₀) after CSFV challenge.